« Return to News | Clinical Intelligence

Giant leap for HIV cure

Wednesday, January 11, 2012 11:09 AM

After 30 years of unsuccessful attempts, an HIV vaccine may be within reach. That’s what scientists at Crucell NV of the Netherlands (a subsidiary of Johnson & Johnson) are saying.

Crucell NV has successfully used a vaccine to protect monkeys from contracting its version of the HIV virus, SIV (simian immunodeficiency virus). After combining SIV proteins with different cold and pox viruses, scientists vaccinated monkeys, and then repeatedly exposed them to a genetically different SIV variation.

As few as 12% of monkeys exposed to the virus became infected after the first of six exposures, while monkeys treated with a placebo were infected 75% of the time. Although 12% may not sound like a lot, Crucell NV explained that SIV is nearly 100 times more infections than HIV.

A human trial is being planned by Harvard Medical School and U.S. Military HIV Research Program. The vaccine will be combined with a booster shot developed by the U.S. military and the National Institute of Allergy and Infectious Diseases.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.